Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Grand View Research | PRODUCT CODE: 1631196

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1631196

Helicobacter Pylori Diagnostics Market Analysis Report By Type (Instruments, Reagents, Services), By Technology (Immunoassays, POC, Molecular Diagnostics), By End Use, By Region And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Helicobacter Pylori Diagnostics Market Growth & Trends:

The global helicobacter pylori diagnostics market size is anticipated to reach USD 966.19 million by 2030, expanding at a CAGR of 5.87% from 2025 to 2030, according to a new report by Grand View Research. Increasing demand for personalized antibiotic therapy coupled with improved cost-effectiveness Helicobacter pylori (H. pylori) infection diagnosis is projected to drive the growth.

Easy accessibility and affordability of antibiotics along with short treatment durations will boost the adoption of antibiotics as well as the demand for pre and post monitoring tests. Furthermore, factors such as rising incidence of H. pylori infections, need for early diagnosis, and rapid technological advancements in diagnostic techniques will propel the market growth. However, rising pressure of maintaining economic pricing due to the extremely competitive environment may hinder the growth of the Helicobacter pylori diagnostics market.

H. pylori is an aerobic gram-negative bacteria generally found in the stomach. Although advantageous for balancing the stomach ecology, it can cause infection to the inner stomach lining. The bacteria can act as one of the causative agents for stomach cancer, duodenal ulcers, gastritis and gastric ulcers, and infection to the small intestine, among other conditions. This has led to an increase in the demand for Helicobacter pylori diagnostics that enable early detection of H. pylori infection. Patients are subject to an antibiotic therapy for 10 to 14 days, in case of positive diagnosis of ulcers caused by this bacteria. Treatment for H. pylori could include a combination of antibiotics such as metronidazole, amoxicillin, clarithromycin, tetracycline, or with a proton pump inhibitor, ranitidine bismuth citrate, and bismuth subsalicylate.

The immunoassay technology segment held the largest market share in 2018 and is expected to register the fastest CAGR over the forecast period. In terms of end user, the hospital segment held the largest market share in 2018, while diagnostic laboratories is anticipated to expand at the fastest CAGR in the forthcoming years. In terms of region, North America led the global market for Helicobacter pylori diagnostics. Asia Pacific, on the other hand, is expected to witness the fastest CAGR from 2019 to 2026.

Helicobacter Pylori Diagnostics Market Report Highlights:

  • Immunoassays technology held the largest market share in 2024 and is expected to witness the fastest CAGR over the forecast period
  • Among end user, hospital segment held the largest market share in 2024, while the diagnostics laboratories segment is expected to demonstrate the fastest CAGR from 2025 to 2030
  • Latin America is anticipated to grow at the fastest CAGR of 6.4% in the forecast period owing to the rising importance to the healthcare sector, increasing infectious diseases prevalence, and awareness.
Show more
Product Code: GVR-3-68038-699-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
  • 3.5. Market Restraint Analysis
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Type Business Analysis

  • 4.1. Helicobacter Pylori Diagnostics Market: Type Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.3. Reagents
    • 4.3.1. Reagents Market, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Helicobacter Pylori Diagnostics Market: Technology Movement Analysis
  • 5.2. Immunoassays
    • 5.2.1. Immunoassays Market, 2018 - 2030 (USD Million)
  • 5.3. POC
    • 5.3.1. POC Market, 2018 - 2030 (USD Million)
  • 5.4. Molecular Diagnostics
    • 5.4.1. Molecular Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 6. End use Business Analysis

  • 6.1. Helicobacter Pylori Diagnostics Market: End use Movement Analysis
  • 6.2. Hospitals
    • 6.2.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.3. Diagnostics Laboratories
    • 6.3.1. Diagnostics Laboratories Market, 2018 - 2030 (USD Million)
  • 6.4. Clinics
    • 6.4.1. Clinics Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Helicobacter Pylori Diagnostics Market Share By Region, 2024 & 2030
  • 7.2. North America
    • 7.2.1. North America Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target Disease Prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. Regulatory Framework
      • 7.2.2.5. Reimbursement Scenario
      • 7.2.2.6. U.S. Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. Canada Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Reimbursement Scenario
      • 7.2.4.6. Mexico Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. Reimbursement Scenario
      • 7.3.2.6. Germany Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. UK Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. France Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. Italy Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Spain Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Denmark Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Sweden Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Norway Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Reimbursement Scenario
      • 7.4.2.6. Japan Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. China Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. India Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. South Korea Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. Australia Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Thailand Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Reimbursement Scenario
      • 7.5.2.6. Brazil Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Argentina Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. Reimbursement Scenario
      • 7.6.2.6. South Africa Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. Saudi Arabia Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. UAE Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. Kuwait Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Biohit Oyj
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Collection Site Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Thermo Fisher Scientific, Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Collection Site Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Quest Diagnostics Incorporated
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Collection Site Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Meridian Bioscience
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Collection Site Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Rad Laboratories
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Collection Site Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Alpha Laboratories Ltd
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Collection Site Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Coris BioConcept
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Collection Site Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. F. Hoffmann-La Roche AG
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Collection Site Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Certest Biotec
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Collection Site Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Epitope Diagnostics, Inc.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Collection Site Benchmarking
      • 8.4.10.4. Strategic Initiatives
Show more
Product Code: GVR-3-68038-699-8

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 5 Global Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 6 Global Helicobacter Pylori Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 9 North America Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 10 North America Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 13 U.S. Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 14 Mexico Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 15 Mexico Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16 Mexico Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 17 Canada Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19 Canada Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 20 Europe Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Europe Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 24 Germany Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 25 Germany Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 26 Germany Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 27 UK Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 28 UK Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29 UK Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 30 France Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 France Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 32 France Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 33 Italy Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 35 Italy Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 36 Spain Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 Spain Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 38 Spain Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 40 Denmark Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Denmark Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Sweden Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Sweden Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 45 Norway Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 46 Norway Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Norway Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 52 China Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 China Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 54 China Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 55 Japan Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 56 Japan Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Japan Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 58 India Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 India Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 India Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 61 South Korea Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 South Korea Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 63 South Korea Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 64 Australia Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 65 Australia Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 Australia Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Thailand Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 Thailand Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 Latin America Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Latin America Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 75 Brazil Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 76 Brazil Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 79 Argentina Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 South Africa Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 90 UAE Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 92 UAE Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Helicobacter Pylori Diagnostics Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Helicobacter Pylori Diagnostics Market: Type Movement Analysis
  • Fig. 16 Global Helicobacter Pylori Diagnostics Market: for Instruments, 2018 - 2030 (USD Million)
  • Fig. 17 Global Helicobacter Pylori Diagnostics Market: for Reagents, 2018 - 2030 (USD Million)
  • Fig. 18 Global Helicobacter Pylori Diagnostics Market: for Services, 2018 - 2030 (USD Million)
  • Fig. 19 Global Helicobacter Pylori Diagnostics Market: Technology Movement Analysis
  • Fig. 20 Global Helicobacter Pylori Diagnostics Market: for Immunoassays, 2018 - 2030 (USD Million)
  • Fig. 21 Global Helicobacter Pylori Diagnostics Market: for POC, 2018 - 2030 (USD Million)
  • Fig. 22 Global Helicobacter Pylori Diagnostics Market: for Molecular Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 23 Global Helicobacter Pylori Diagnostics Market: End use Movement Analysis
  • Fig. 24 Global Helicobacter Pylori Diagnostics Market: for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 25 Global Helicobacter Pylori Diagnostics Market: for Diagnostics Laboratories, 2018 - 2030 (USD Million)
  • Fig. 26 Global Helicobacter Pylori Diagnostics Market: for Clinics, 2018 - 2030 (USD Million)
  • Fig. 27 Regional Marketplace: Key Takeaways
  • Fig. 28 Regional Outlook, 2024 & 2030
  • Fig. 29 Global Helicobacter Pylori Diagnostics Market: Region Movement Analysis
  • Fig. 30 North America Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 32 Canada Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 34 Europe Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 35 Germany Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 36 UK Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 37 France Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 38 Italy Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 39 Spain Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 40 Denmark Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 41 Sweden Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 42 Norway Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 44 Japan Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 45 China Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 46 India Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 47 Australia Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 48 South Korea Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 49 Thailand Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 52 Argentina Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 54 South Africa Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 56 UAE Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!